CPT1A and gastric cancer: In gastric cancer, CPT1A is associated with the malignant phenotype of gastric cancer cells, and its higher protein levels tend to predict and shorten the survival time, so it can be used as a good prognostic bioindicator for the diagnosis and treatment of gastric cancer patients [75].